Axovant Sciences has signed an exclusive worldwide licensing agreement with Oxford BioMedica to develop and commercialise, OXB-10, to treat Parkinson’s disease. Through using LentiVector platform, Oxford BioMedica has developed OXB-102 gene therapy for Parkinson’s […]
OptiBiotix Health has entered into a five year agreement with Akums Drugs and Pharmaceuticals to exclusively manufacture and supply products featuring OptiBiotix’s cholesterol and blood pressure reducing strain LPLDL in India. The agreement is […]
SMi Reports: There are only 3 places left, in 1 week leading industry experts within the microbiology community will be meeting in San Diego at SMi’s largest Pharmaceutical Microbiology West Coast conference! The field of […]
SMi Reports: 13th annual ADMET conference chairman Dr Eric Blomme’s invitation and speaker interview is now available to download The 13th annual ADMET conference, commencing 9 – 10 July 2018 in London, UK, will be […]